| Name | Benchmark Holdings |
|---|---|
| Epic | BMK |
| Isin | GB00BGHPT808 |
| Index | AIM50 AIM350 |
| Industry | Pharmaceuticals & Biotechnology |
| Latest share price | 29.80p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £220.62 | Debt ratio | n/a |
| Shares in issue | 739.79 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | -2.61 |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -2.41 | 52-week high / low | 27.50p / 48.00p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | Benchmark Holdings |
|---|---|
| Address | Highdown House, Yeoman Way, Worthing, West Sussex, United Kingdom, BN99 3HH |
| Telephone | |
| Website | http://www.bmkholdings.com |
| Director | Position |
|---|---|
| Mr Trond Williksen | CEO |
| Mrs Septima Maguire | CFO |
| Mr Peter George | Chairman |
| Mr Torgeir Svae | Non-Executive Director |
| Mr Marie Danielsson | Non-Executive Director |
| Mr Jonathan Esfandi | Non-Executive Director |
| Mr Kristian Eikre | Non-Executive Director |
| Mr Yngve Myhre | Non-Executive Director |
| Ms Jennifer Haddouk | Company Secretary |
| Assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 30/09/23 | 30/09/22 | 30/09/21 |
| Intangible asssets and goodwill | 206.08 | 245.26 | 229.04 |
| Investments and other non-current assets | 0.01 | 0.01 | 0.01 |
| Total non-current assets | 321.27 | 378.2 | 357.96 |
| Inventory / work in progress | 25.27 | 29.81 | 20.95 |
| Trade and other receivables | 59.79 | 56.38 | 46.5 |
| Cash and equivalents | 36.52 | 36.4 | 39.46 |
| Other current assets and asset held for resale | 27.59 | 25.78 | 17.12 |
| Total of all assets | 471.3 | 526.57 | 481.99 |
| Liabilities £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | 75.08 | 73.26 | 63.52 |
| Long term liabilities | 113.6 | 130.03 | 138.87 |
| Other liabilites / pension etc | n/a | n/a | n/a |
| Total of all liabilities | 188.68 | 203.29 | 202.39 |
| Net assets £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 282.62 | 323.29 | 279.6 |
| Equity £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | 0.74 | 0.7 | 0.67 |
| Minority interests | 6.21 | 9.89 | 7.88 |
| Retained earnings | 183.49 | -185.14 | 30.46 |
| Share premium account | n/a | n/a | 400.68 |
| Total equity | 282.62 | 323.29 | 279.6 |
| Income £ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -5.32 | -6.23 | -5.38 |
| Pre-tax profit | -12.69 | -21.38 | -9.18 |